Antinociception of β-d-glucan from Pleurotus pulmonarius is possibly related to protein kinase C inhibition  by Baggio, Cristiane Hatsuko et al.
A
p
C
d
M
a
b
c
d
F
a
A
R
R
A
A
K

P
N
T
P
1
(
c
t
[
a
h
d
R
(
a
i
b
d
a
r
0
dInternational Journal of Biological Macromolecules 50 (2012) 872– 877
Contents lists available at SciVerse ScienceDirect
International  Journal  of  Biological  Macromolecules
journa l h o me  pag e: www.elsev ier .com/ locate / i jb iomac
ntinociception  of  -d-glucan  from  Pleurotus  pulmonarius  is  possibly  related  to
rotein  kinase  C  inhibition
ristiane  Hatsuko  Baggioa,  Cristina  Setim  Freitasa, Rodrigo  Marconb, Maria  Fernanda
e  Paula  Wernera,b, Giles  Alexander  Raeb, Fhernanda  Ribeiro  Smiderlec, Guilherme  Lanzi  Sassaki c,
arcello  Iacominic, Maria  Consuelo  Andrade  Marquesa,  Adair  Roberto  Soares  Santosd,∗
Department of Pharmacology, Sector of Biological Sciences, Federal University of Paraná, Curitiba, PR, Brazil
Department of Pharmacology, Center of Biological Sciences, Federal University of Santa Catarina, Florianópolis, SC, Brazil
Department of Biochemistry and Molecular Biology, Sector of Biological Sciences, Federal University of Paraná, Curitiba, PR, Brazil
Laboratory of Neurobiology of Pain and Inﬂammation, Department of Physiological Sciences, Center of Biological Sciences, Federal University of Santa Catarina, 88040-900
lorianópolis, SC, Brazil
 r  t  i  c  l  e  i  n  f  o
rticle history:
eceived 15 September 2011
eceived in revised form 24 October 2011
ccepted 31 October 2011
vailable online 6 November 2011
a  b  s  t  r  a  c  t
-d-Glucan,  a  polysaccharide  isolated  from  an  edible  mushroom  Pleurotus  pulmonarius  (Fr.)  Quel.,  pre-
sented  antinociceptive  activity  in mice.  This  study  evaluated  the  involvement  of transient  receptor
potential  (TRP)  channels  and  protein  kinase  C (PKC)  on  antinociceptive  effect  of a (1→3),(1→6)-linked
-d-glucan  (GL)  in  mice.  Intraperitoneal  administration  of  GL  potently  inhibited  nociceptive  responses
induced  by intraplantar  injections  of  capsaicin,  cinnamaldehyde,  menthol,  acidiﬁed  saline  and  phorboleywords:
-d-Glucan
leurotus pulmonarius
ociception
RP channels
KC
myristate  acetate  (PMA).  Moreover,  Western  blot  analysis  revealed  that GL  treatment  also  prevented
PMA-induced  PKC  activation.  Collectively,  present  results  demonstrate  that  GL  could  constitute  an
attractive  molecule  of  interest  for the  development  of  new  analgesic  drugs.
© 2011 Elsevier B.V. Open access under the Elsevier OA license. . Introduction
Phytochemical studies carried out with Pleurotus pulmonarius
Fr.) Quel., an edible mushroom used in Chinese cuisine, revealed it
ontains several polysaccharides, alongside a high amount of pro-
eins, essential amino acids and vitamins, but no lipids or starch
1,2]. Among these polysaccharides are xyloglucan, mannogalactan
nd -d-glucan [3–5]. Interestingly, a variety of biological effects
ave been ascribed to -d-glucans, namely antitumoral, antioxi-
ant, anti-inﬂammatory and immunomodulatory properties [6–9].
ecently, our group reported that (1→3),(1→6)-linked -d-glucan
GL) isolated from P. pulmonarius attenuated nociceptive responses,
s well as inhibited leukocyte migration and plasma extravasation
nduced by acetic acid in mice [4].  It was also found to inhibit
oth phases of formalin-induced licking in mice. Besides, it was
emonstrated that GL presented antinociceptive effects in acute
nd neuropathic pain with participation of ionotropic glutamate
eceptors and pro-inﬂammatory cytokine (IL-1) [10].
∗ Corresponding author. Tel.: +55 48 3721 9444x206; fax: +55 48 3721 9672.
E-mail address: arssantos@ccb.ufsc.br (A.R.S. Santos).
141-8130 ©  2011 Elsevier B.V.   
oi:10.1016/j.ijbiomac.2011.10.023
Open access under the Elsevier OA license. Pain is a physiologically relevant sensation necessary to detect
and/or prevent injury, but it often outlives its usefulness as a
warning system to become chronic and debilitating [11,12].  Pain
signaling to the central nervous system is initiated when noxious
stimuli excite primary afferent nociceptive C and A ﬁbers, fre-
quently by activation of several types of ionotropic channels and
metabotropic receptors [13,14]. In fact, transient receptor potential
(TRP) and acid-sensing ion channels (ASIC) participate in gener-
ating nociceptive signals in response to various speciﬁc noxious
stimuli [14–16].  Activity of some of these channels, as well as of
other proteins implicated in nociceptive signaling pathways can be
upregulated by protein kinase C (PKC) [17–19].  Intraplantar injec-
tion of phorbol 12-myristate 13-acetate (PMA), a PKC activator,
induces nociceptive responses which are associated with translo-
cation of PKC isoforms from cytoplasmic to membrane of primary
afferent nerves, thus indicating that their activation is implicated
in peripheral nociception [12,18].
In the present study, we  sought to evaluate the effect of GL
on the overt nociception triggered by intraplantar protons (activa-
tor of ASIC/TRPV1 channels), capsaicin (agonist of TRPV1 channel),
cinnamaldehyde (agonist of TRPA1 channel), menthol (agonist of
TRPM8 channel) and PMA  (a direct activator of PKC) injection into
the hind paw. Finally, we  also evaluated the participation of the
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KC pathway on the antinociceptive effect of GL on PMA  test using
estern blot analysis.
. Materials and methods
.1. Animals
Experiments were conducted using Swiss mice (25–35 g) of both
exes, housed at 22 ± 2 ◦C under a 12/12 h light/dark cycle (lights on
t 06:00) and with free access to food and water. Male and female
ice were distributed equally among groups and acclimatized to
he laboratory conditions for at least 1 h before testing. Each animal
as used only once. All experiments were performed after approval
f the respective protocols by the Institutional Ethics Committee
nd were carried out in accordance with the current guidelines for
he care of laboratory animals and the ethical guidelines for investi-
ations of experimental pain in conscious animals [20]. The number
f animals and intensities of noxious stimuli used were the mini-
um  necessary to demonstrate the consistent effects of the drug
reatments.
.2. Isolation and characterization of the puriﬁed ˇ-d-glucan
The (1→3),(1→6)-linked -d-glucan (GL) was isolated from the
ushroom P. pulmonarius (Fr.) Quel. by Smiderle et al. [4].  The
olysaccharide fraction was obtained from milled mushroom via
ot aqueous extraction, and was submitted to a freeze–thawing
rocess [21]. Partial precipitation took place and centrifugation
ave rise to an insoluble fraction, which was treated with aqueous
odium hydroxide at 80 ◦C and resubmitted to the freeze–thawing
rocess. The soluble fraction then obtained was  composed of glu-
ose, and showed a degree of purity greater than 98%. Methylation
nalysis, controlled Smith degradation, and mono- and bidimen-
ional nuclear magnetic resonance (NMR) spectroscopy conﬁrmed
he linkage type and main chain conﬁguration elucidated for this
-d-glucan, which is depicted in Fig. 1. This polysaccharide was
stimated to be a high molecular weight (between 1 × 105 and
 × 106 g/mol) based on previously data published for other Pleu-
otus’ glucans [8,22].
.3. Nociception induced by capsaicin, cinnamaldehyde, menthol
nd acidiﬁed saline
To test if TRPV1, TRPA1, TRPM8 and ASIC receptors consti-
ute potential speciﬁc targets for the antinociceptive actions of GL,
e tested the effects of the later against nociceptive responses
licited by activators of each channel. To this effect, following
ystemic treatment with GL or other drugs (see details below),
ice received a single 20 l intraplantar (i.pl.) injection of either-d-glucan isolated from Pleurotus pulmonarius.
capsaicin (5.2 nmol/paw), cinnamaldehyde (10 nmol/paw), men-
thol (1.2 mol/paw), acidiﬁed saline (2% acetic acid in 0.9% saline,
pH 1.98/paw) or the corresponding vehicle, delivered into the
ventral surface of the right hind paw. Each animal was then
placed, immediately and alone, into a glass cylinder of 20 cm
diameter positioned on a platform in front of a mirror to enable
full view of hind paws. The amount of time spent licking the
injected paw, used as an index of nociceptive behavior inten-
sity, was  recorded with a chronometer for 5 min  (for capsaicin
or cinnamaldehyde) or 20 min  (menthol and acid saline). Thirty
minutes prior to i.pl. injection of the nociceptive agent, the
mice were treated with GL (0.1–100 mg/kg i.p.), ruthenium red
(nonselective TRP antagonist, RR, 3 mg/kg i.p.), camphor (TRPA1
antagonist, CAM, 7.6 mg/kg s.c.) or amiloride (the epithelial Na+
channel blocker, AML, 100 mg/kg i.p.). In another set of experi-
ments, GL (10 and 30 g/paw) or GF109203X (1 nmol/paw), a PKC
inhibitor, was  co-administered to the hindpaw together with cap-
saicin (5.2 nmol/paw), cinnamaldehyde (10 nmol/paw), menthol
(1.2 mol/paw) or acidiﬁed saline (2% acetic acid in 0.9% saline, pH
1.98/paw) and the behavioral responses were recorded as described
above.
2.4. Nociception induced by PMA
To assess the inﬂuence of GL (10, 30 and 100 mg/kg i.p.) on PKC-
dependent nociception, nociceptive responses were induced by
i.pl. injection of PMA  (500 pmol/paw), an activator of PKC. In such
experiments, only the licking time accumulated 15–45 min  follow-
ing injection was  recorded [23]. Control animals received vehicle
(saline, 10 ml/kg i.p.). Procedures, doses and administration routes
of the various drugs were chosen on the basis of previous studies
[18,23–25] or preliminary experiments.
2.5. Western blot studies
In order to evaluate the effect of GL on PMA-induced PKC
activation in hind paw skin, Western blot analysis for PKC was
carried out essentially as described by Ferreira et al. [18]. The
mice received GL (100 mg/kg i.p.) or vehicle (saline, 10 ml/kg i.p.)
30 min  before i.pl. injection of PMA  (500 pmol/paw) or vehicle
(phosphate-buffered saline, PBS) into the right hind paw. Fifteen
minutes later, the animals were killed with cervical dislocation and
the skin and connective tissues of the plantar portion of the injected
paw was carefully removed and disrupted using a glass Potter
homogenizer in ice-cold buffer containing protease and phos-
phatase inhibitors (100 mM Tris–HCl, 2 mM EDTA, 2 g aprotinin,
0.1 mM  phenylmethylsulfonyl ﬂuoride, 200 mM NaF and 2 mM
sodium orthovanadate, pH 7.4). The homogenate was  centrifuged
at 1000 × g for 10 min  at 4 ◦C. The resulting supernatant was further
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Fig. 2. Effect of GL (3–100 mg/kg i.p.) on hind paw licking induced by i.pl. injection of capsaicin (panel A), cinnamaldehyde (panel B), acidiﬁed saline (panel C) or menthol
(panel D) in mice. Mice were treated with GL (i.p. at the doses indicated), ruthenium red (RR, 3 mg/kg i.p.), camphor (CAM, 7.6 mg/kg s.c.), amiloride (AML, 100 mg/kg i.p.) or
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ealine  (C, 10 ml/kg) 30 min  prior to the i.pl. injection. Each column represents the me
y  **p < 0.01 and ***p < 0.001 (ANOVA followed by Newman–Keuls’ test).
entrifuged at 35,000 × g for 30 min  at 4 ◦C. The new supernatant
as collected as a cytoplasm-rich fraction, whereas the pellet was
esuspended and considered as a membrane-rich fraction. After
etermining protein content in each sample, using the Bradford
rotein assay kit (Bio-Rad, Hercules, CA, USA), equivalent amounts
f protein (50 g) were mixed in buffer (200 mM Tris, 2.75 mM b-
ercaptoethanol, 10% glycerol, 2% SDS, 0.04% bromophenol blue)
nd boiled for 5 min. Proteins were resolved in 10% SDS poly-
crilamide gel by electrophoresis (SDS–PAGE), transferred onto
olyvinylidene diﬂuoride membranes according to manufacturer’s
nstructions (Millipore/Amersham Biosciences, Buckinghamshire,
K) and saturated by incubation overnight with 10% nonfat dry
ilk solution, 60 min  incubation with 1.5% gelatin and then incuba-
ion with anti-PKC antibody overnight (diluted 1:1 000, Santa Cruz
iotechnology, Inc., Santa Cruz, CA). After washing, the membranes
ere incubated with adjusted peroxidase-coupled secondary anti-
ody (diluted 1:6000, Santa Cruz Biotechnology Inc., Santa Cruz, CA)
or 1 h. Immunocomplexes were visualized using the ECL chemi-
uminescence detection system (GE Healthcare, Little Chalfont,
uckinghamshire, UK). The optical densities of speciﬁc bands were
easured with an imaging analysis system (Scion Image for Win-
ows, Frederick, MD,  USA) and expressed in arbitrary units.
.6. Drugs and reagents
Amiloride, camphor, capsaicin, cinnamaldehyde, GF109203X,
enthol, phorbol 12-myristate 13-acetate and PBS tablets were
rom Sigma–Aldrich (St. Louis, MO). All other chemicals were of
nalytical grade and obtained from standard commercial suppli-
rs. Drugs were dissolved in 0.9% NaCl solution, with the exceptionEM (n = 6–8). Signiﬁcance levels when compared to the control group are indicated
of capsaicin, which was  dissolved in 10% ethanol in saline, and men-
thol, which was  dissolved in 1.6% ethanol/0.01% Tween 80 in saline.
In both of these conditions, the ﬁnal solutions containing ethanol
failed to cause any nociceptive effects per se when administered
alone.
2.7. Statistical analysis
The results are presented as means ± standard error of the mean
(SEM), except the ID50 values for GL (i.e., the dose that reduced
the nociceptive response by 50% relative to control values), which
are reported as geometric means accompanied by their respective
95% conﬁdence limits. The ID50 values were determined by nonlin-
ear regression from individual experiments using linear regression
Graph-Pad software (GraphPad software, San Diego, CA, USA). The
percentages of inhibition were calculated for the most effective
dose used. Statistical differences between groups were analyzed
by one-way ANOVA followed by Newman–Keuls’ test. Comparisons
between the protein optical densities determined in the Western
blot studies were made using two-tailed unpaired Student’s t-test.
In all cases, differences were considered to be signiﬁcant when
P < 0.05.
3. Results
3.1. Effects of GL on nociception induced by capsaicin,
cinnamaldehyde, menthol and acidiﬁed saline
The i.p. administration of GL (3–30 mg/kg) produced dose-
related inhibition of the licking induced by capsaicin (Fig. 2A). GL
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Table 1
Effect of GF109203X, a PKC inhibitor, on nociceptive responses of mice to i.pl. injec-
tions of capsaicin, cinnamaldehyde, menthol or acidiﬁed acid in the hind paw.
Chemical noxious stimulus % Inhibition
Capsaicin (5.2 nmol/paw) 42 ± 8
Cinnamaldehyde (10 nmol/paw) n.i.
Menthol (1.2 mol/paw) 85 ± 6
Acidiﬁed saline (pH 1.98/paw) n.i.
Values represent the mean ± SEM of groups of 6–8 mice. GF109203X (1 nmol/paw)
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Fig. 3. Effect of GL on PMA-induced hind paw licking in mice (panel A) and ex
vivo  PKC translocation from cytosolic- to membrane-enriched fractions of hind
paw homogenates (panels B and C). GL (10–100 mg/kg) or saline (C, 10 ml/kg) were
administered i.p. 30 min  prior to i.pl. PMA  injection. Nociceptive responses were
recorded 15–45 min after i.pl. treatment. Skin samples were collected at 45 min
after  i.pl. injection, homogenized, processed to yield both fractions and analyzed
by  Western blot as described in Section 2. Each column represents the mean ± SEM
(n  = 6–8). Signiﬁcance levels are indicated by *p < 0.05, **p < 0.01 and ***p < 0.001
when compared to the control group and by ##p < 0.01 when compared to the naive
group (ANOVA followed by Newman–Keuls’ test in panel A; Student’s t-test in panelsas  co-injected with the algogen. n.i.: not inhibited.
isplayed a mean ID50 of 8.1 mg/kg (95% conﬁdence limits 5.9–11.3)
t the 30-min time point and, at 30 mg/kg, inhibited capsaicin-
nduced responses by 92 ± 4%, an extent similar to that caused by
uthenium red (3 mg/kg i.p.; 87 ± 2%), used as a positive control.
ikewise, GL was also effective in reducing nociceptive responses
o cinnamaldehyde, acidiﬁed saline and menthol, yielding ID50s of
3.8 (9.6–19.8), 29.8 (20.0–44.4) and 0.2 (0.1–0.4) mg/kg, respec-
ively (Fig. 2B, C and D, respectively). Moreover, at 30 mg/kg,
L was as effective as camphor (7.6 mg/kg s.c.) in inhibiting
ociception induced by cinnamaldehyde (67 ± 12% vs 57 ± 6% inhi-
ition, respectively; Fig. 2B), and more effective than amiloride
100 mg/kg i.p.) in reducing that caused by acidiﬁed saline (89 ± 1%
s 65 ± 5% inhibition, respectively; Fig. 2C). Remarkably, a smaller
ose of GL (10 mg/kg i.p.) abrogated menthol-induced hind paw
icking entirely (97 ± 1% inhibition; Fig. 2D).
Intraplantar co-administration of GL (10 and 30 g/paw) did not
lter the nociceptive responses induced by capsaicin, cinnamalde-
yde, menthol and acidiﬁed saline (data not shown). Whereas
he GF109203X, an inhibitor of PKC, together with capsaicin or
enthol inhibited the nociceptive responses to these algogens by
2 ± 8% and 85 ± 6%, respectively (Table 1). However, co-injection
f GF109203X failed to affect nociceptive responses to either cin-
amaldehyde or acidiﬁed saline (Table 1).
.2. Effects of GL on PMA-induced nociception and activation of
rotein kinase C
The i.p. administration of GL (10–100 mg/kg) produced
ose-related inhibition of hind paw licking induced by
MA  (500 pmol/paw), yielding a mean ID50 value of 17.5
11.0–28.0) mg/kg and full (100%) suppression at the dose of
00 mg/kg (Fig. 3A). Western blot analysis of hind paw skin sam-
les conﬁrmed that i.pl. PMA  (500 pmol/site) injection activated
KC, i.e. induced translocation of PKC from the cytosolic- to
embrane-rich fraction (Fig. 3B and C). Systemic treatment with
L (100 mg/kg i.p.), 30 min  prior to PMA  injection, abrogated the
ranslocation of PKC induced by the direct activator of PKC.
. Discussion
The results of the current study demonstrate that i.p. admin-
stration of GL, a -d-glucan isolated from the mushroom P.
ulmonarius, exerts potent antinociceptive effects against noci-
eption induced in the hind paw by capsaicin, cinnamaldehyde,
enthol, acidiﬁed saline and PMA. Of interest, results obtained ex
ivo identiﬁed PKC as a potentially relevant molecular target of GL
ction to suppress nociception in mice.
In a previous study, we observed that GL is endowed with potent
ntinociceptive activity against abdominal constrictions induced
y acetic acid, and promotes potential anti-inﬂammatory effects
ncluding inhibition of plasma extravasation and leukocyte migra-
ion into the peritoneal cavity of mice [4].  GL was also shownB  and C).
to inhibit both ﬁrst and second phases of formalin-induced noci-
ceptive responses in mice. In addition, we  have shown that GL
inhibits the nociceptive responses triggered by IL-1 and by gluta-
mate, mainly by inhibiting the activation of ionotropic glutamate
receptor pathways [10]. Moreover, GL demonstrated an interest-
ing antinociception against neuropathic pain induced by partial
ligature of sciatic nerve, however, the mechanisms underlying
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hese antinociceptive effects remained largely unidentiﬁed. A bet-
er understanding of the mode of action of GL would enhance
he potential therapeutic interest on this naturally occurring -d-
lucan.
Several ion channels play an essential role in the ability of
ociceptors (C and A ﬁbers) to detect and discriminate noxious
hermal, mechanical and chemical stimuli and convey this sen-
ory information to second order nociceptive neurons of the dorsal
orn of spinal cord [16]. In the present study, we observed that GL
ffectively inhibited nociceptive responses induced by i.pl. injec-
ions of capsaicin or cinnamaldehyde, which are highly selective
ctivators/agonists of TRPV1 and TRPA1 channels, respectively, as
ell as menthol (a preferential TRPM8 channel agonist that can
lso activate TRPA1 channels at higher concentrations) or acidi-
ed saline (which activates TRPV1 and ASIC channels). Importantly,
e conﬁrmed that the nociceptive responses elicited by capsaicin,
innamaldehyde and acidiﬁed saline were extensively inhibited by
rior treatment with antagonists of their respective speciﬁc or pref-
rential targets, i.e. ruthenium red (TRPV1), camphor (TRPA1) and
miloride (ASIC). Due to the lack of a suitable selective antago-
ist, we were unable to determine if responses to menthol resulted
rom activation of TRPM8 channels. In addition, the potency of
L in inhibiting cinnamaldehyde-induced nociception is in excel-
ent agreement with that previously observed in the model of
ormalin-induced hind paw nociception [4],  especially consider-
ng that formalin is an activator of TRPA1 channels [26]. These
esults strengthen considerably the evidence that GL is an effective
nalgesic in rodents.
However, it appears most unlikely that GL induces antinoci-
eption by selectively antagonizing the binding of capsaicin,
innamaldehyde, menthol or protons to their respective target
hannels, which was supported by the no alteration of nociceptive
esponses when the GL was co-administered with these acti-
ators/agonists. It was demonstrated that capsaicin, stimulating
RPV1 receptor, mediate the release of several neurotransmitters,
ncluding glutamate; besides, menthol (TRPM8 agonist) and allyl
sothiocyanate (TRPA1 agonist) enhance spontaneous glutamater-
ic synaptic transmission onto lamina II neurones in spinal cord
lices [27–29].  Indeed, we previously demonstrated that GL inhib-
ted the nociceptive responses induced by injection of intrathecal
xcitatory amino acids [10], suggesting that the GL effect seems to
e partially related to inhibition of glutamate release in the dorsal
orn after peripheral stimulation of TRPs.
We also observed that GL effectively inhibited nociceptive
esponses to i.pl. injection of PMA, a direct activator of PKC
18]. Given the extensive evidence implicating PKC in signaling
echanisms leading to nociception and hyperalgesia [30], we
ypothesized that this could constitute a potentially relevant target
or the antinociceptive action of GL. In this regard, using Western
lot analysis, we obtained ex vivo evidence that i.pl. PMA  injection
learly promoted the translocation of PKC from the cytosolic- to
he membrane-enriched fractions of hind paw skin homogenates,
s would be expected of a PKC activator [18]. More importantly,
rior i.p. treatment of the animal with GL, at a dose promot-
ng effective analgesia, fully prevented this PMA-induced PKC
ranslocation. In addition, we found that GF109203X, a selective
KC inhibitor [18], inhibited nociceptive responses induced by i.pl.
njection of capsaicin and menthol. However, unlike GL, GF109203X
id not inﬂuence responses induced by either cinnamaldehyde or
cidiﬁed saline. As the phosphorylation of TRPV1 by PKC sensi-
izes this channel to activation by capsaicin [31], blockade of this
rocess by GL might account for the analgesic effect of GL (and
F109203X) against capsaicin-induced nociception. Nonetheless,
his does not appear to be a plausible explanation for its inhibitory
ffects on nociception induced by menthol, cinnamaldehyde or pro-
ons (i.e. acidiﬁed saline), as PKC actually dephosphorylates and
[
[
[
[gical Macromolecules 50 (2012) 872– 877
downregulates TRPM8 channels [19], does not contribute to the
sensitization of TRPA1 channels [32] and appears to phosphorylate
and sensitize only ASIC channels containing ASIC2 subunits [17,33],
which are poorly expressed by DRG neurons [34].
It is interesting to note, however, that the antinociceptive pro-
ﬁle of action of GF109203X (i.e. more effective against responses
induced by menthol than capsaicin and inactive against cin-
namaldehyde or acidiﬁed saline) was  remarkably similar to that
of GL, which displayed an ID50 against nociception triggered
by menthol that was 42-, 72- and 156-fold lower than those
obtained against responses induced by capsaicin, cinnamaldehyde
and acidiﬁed saline, respectively. Therefore, the collected evi-
dence strongly suggests that the antinociceptive effects of GL are
associated, at least to a signiﬁcant extent, to inhibition of PKC
activation.
In conclusion, the current study demonstrates that GL, a
naturally occurring -d-glucan, displays pronounced systemic
antinociceptive properties in chemical models of nociception
models in mice. The mechanisms underlying GL-induced antinoci-
ception appear to involve inhibition of PKC. It remains to be
determined if GL also has other potentially relevant targets for its
antinociceptive actions and if it is a selective inhibitor of PKC or
can also block activity of other PKC isoforms.
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